Major adverse cardiovascular events in survivors of immune‐mediated thrombotic thrombocytopenic purpura is a research paper published in American Journal of Hematology (2021). On theSindex it has a DataRank of 0. It has been cited 34 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
American Society of Hematology
Grant: Scholar Award
National Heart, Lung, and Blood Institute
Grant: K99HL150594
FWCI
1.25
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals